Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report 1 April - 30 June 2015, Zinzino AB (publ)

Press release (PDF) Press release (PDF) ”Inspire change in life” Dag Bergheim Pettersen, CEO of Zinzino AB HIGHLIGHTSAll of Zinzino’s markets grew in the second around compared with the previous year. Total revenue was SEK 112.2m (79.6m), which corresponds to sales growth of 41 per cent for the group, compared with the previous year. The profit after tax was SEK 4.1m (3.6m), corresponding to earnings per share of SEK 0.13 (0.13). Our gross profit margin

Stora Enso to divest its packaging plant in Komárom, Hungary

STORA ENSO OYJ STOCK EXCHANGE RELEASE 31 August 2015 at 13.00 EETStora Enso has signed an agreement to divest its offset printed micro-flute packaging plant in Komárom, Hungary to Van Genechten Packaging International S.A., a leading Belgian packaging company.  The initial cash consideration for the divestment of the shares is approximately EUR 12 million, subject to customary closing day adjustments. The transaction has no material income statement impact and is expected to be completed within one month.“There have been major changes in the Komárom plant’s customer base, making the

Use of ozone-tolerant cultivars can enhance India’s food security

India’s bread basket, the Indo-Gangetic Plains (IGP), have been classified as a “hot spot” for air pollution. A recent study from the University of Eastern highlights the current status of ozone research in the IGP region, which is agriculturally important and densely populated. To study adverse effects of ozone, field experiments were conducted with local crop cultivars of mustard (Brassica campestris L.) and rice (Oryza sativa L.), and various growth, physiological (gas-exchange), biochemical and yield parameters were studied throughout the growing season. Ethylenediurea (EDU) was used

”Just incredible” says ProLite Gear on Polygiene

Watch Prolite Gear’s “Base Layer Buying Guide” YouTube video and see what Craig Delger and Brad Baumann say about how pure synthetics are the material of choice for trail runners, thanks to exceptional technologies for odor control and moisture management. “I’ve used it (Polygiene) over and over again and am continually impressed with it. It’s something that doesn’t wash out of the fabric because it is permanently embedded in… and you can wear this stuff over and over and it doesn’t stink.” says Brad Baumann “If you haven’t already heard of Polygiene, I predict you’re gonna hear

Notification of reduction in share capital in JM AB (publ)

JM has received permission by the Swedish Companies Registration Office to effect the reduction of share capital with SEK 2,040,554 regarding 2,040,554 shares as per 14 August, 2015 decided at the Annual General Meeting on April 21, 2015. In accordance with Chapter 4, section 9 of the Financial Instruments Trading Act information about the total number of shares is to be announced on the final trading day of the month. After the reduction, the share capital amounts to SEK 75,153,396 and the total number of issued shares in JM AB is 75,153,396. Following the transaction JM holds 847,819

New campaign group, PRS 4 Scotland, puts forward pioneering framework for rented sector in Scotland

A new campaign group is putting forward a pioneering framework for Scotland’s private rented sector (PRS) which serves tenants and addresses the country’s chronic lack of housing.Adding to the debate around PRS as the Scottish Government finalises its Housing Bill, PRS 4 Scotland has been formed by a number of people and businesses who want to see an affordable, strong and well-invested PRS in Scotland. Their goal is to unite all sections of the industry, including housing associations, institutions and tenants behind a unique, evidence-based framework as the basis for a distinct

Ericsson-backed research project breaks new ground in silicon photonic integration

· New silicon photonics chip increases bandwidth, reduces cost and enables optical routing in the cloud and 5G era · First chip now in testing & characterization phase · IRIS project co-funded by European Commission The Ericsson-led IRIS project has produced a silicon photonics switch designed for housing thousands of optical circuits on a single chip. The first chip is now in the test and characterization phase, and if successful the outcome will be major breakthrough for the industry, paving the way for a new generation of optical systems integrated in a single device.

Change in number of shares and votes in AAK AB (publ.)

The incentive programme for senior executives and key employees implemented at the extraordinary general meeting on November 8, 2010 has resulted in the number of shares and votes in the company having increased during August 2015 by 5,000 shares and votes, through conversion of subscription warrants into new shares in the company. As of  August 31, 2015, there are in total 42,165,289 shares and votes in the company.For further information, please contact:Fredrik Nilsson        CFO            Phone: +46 40 627 83 34        Mobile: +46 708 95 22 21 The information is that which

Announcement of change in the total number of votes in AB SKF

Gothenburg, 31 August 2015: Due to a conversion of shares from Series A to Series B in accordance with the Company’s Articles of Association, AB SKF confirms the following.  As per 31 August the Company’s share capital amounts to SEK 1,138,377,670 and the total number of shares amounts to 36,298,533 shares of Series A and 419,052,535 shares of Series B. The number of votes in the Company amounts to 78,203,787.  AB SKF does not hold any own shares.

Trimb acquires YouMedical to build North European OTC platform

Trimb Healthcare AB (“Trimb”) today announced that it has signed an agreement to acquire YouMedical Group BV (“YouMedical”), a Dutch OTC company with operations in key European markets. YouMedical has total annual sales of approximately EUR 16 million, with solid growth and leading brands in niche categories. “Our ambition is to build a leading international OTC company, and this acquisition represents an important step toward that goal. YouMedical gives us a stronger North European OTC platform, from which we intend to roll out our pipeline and pursue other strategic acquisitions. In

Zenterio releases a new version of its independent operating system

Zenterio releases the latest version of their independent operating system, Zenterio OS 15.2 in conjunction with their participation at IBC 2015. Zenterio OS 15.2 comes with a number of new features and improvements that will help operators to deploy interactive TV services both faster, and cheaperImproved OTT supportThe support for OTT services and technologies has been improved thanks to the integration of Microsoft PlayReady 3.0, increased support for HLS version 4 and Smooth Streaming. This enables Operators to quickly add OTT services to their offering in a way that allows for

Basware expands cooperation with major Finnish corporation in the energy and ICT industry by delivering source-to-pay and e-invoicing services

Basware Corporation, stock exchange release, August 31, 2015 at 10:00Basware expands cooperation with major Finnish corporation in the energy and ICT industry by delivering source-to-pay and e-invoicing servicesBasware has signed an agreement on the delivery of source-to-pay and e-invoicing services to a Finnish multinational corporation in the energy and ICT industry. The customer is currently using license-based invoice automation solutions. The new agreement includes a comprehensive source-to-pay solution and inbound e-invoicing. In addition, Basware will deliver a contract

Next generation of “heat power”, delivering 100% clean electricity from hot water with up to 14% efficiency.

Climeon releases new and enhanced range of Climeon Ocean™ and Climeon Ocean Marine™ products. With higher efficiency and effect the new range of Climeon Ocean™ and Climeon Ocean Marine™ products delivers even higher CO2 savings and financial benefits for customers. Based on the patented Climeon C3 technology the ten products ranges from 150 kW to 1 MW.Today, August 31st, Climeon announce it new ranges of Climeon Ocean™ and Climeon Ocean Marine™ products. Based on the successful Climeon Ocean™ 100, these products include more than fifty improvements, including higher efficiency, increase

SciBase’s US Reader Study shows significant improvement in detection of melanoma using Nevisense

SciBase today announces the results from their Reader Study in the US. The results from the study show that the addition of Nevisense significantly improved the ability of US dermatologists to accurately detect melanoma. The Reader Study is an important requirement of the application process to the US Food and Drug Administration (FDA). With the results from the study, SciBase can now compile their complete application.“We are very pleased with the result of the study. This was the last requirement from the US FDA for our Pre-Market Approval (PMA) application for Nevisense on the US market.

Etteplan Oyj's Directed Share Issue

ETTEPLAN OYJ, STOCK EXCHANGE RELEASE, AUGUST 31, 2015, AT 09.35 A.M. ETTEPLAN OYJ’S DIRECTED SHARE ISSUE The Board of Directors of Etteplan Oyj (“Company”) has in its meeting held on August 28, 2015 made a conditional resolution upon Directed Share Issue pursuant to the authorization granted to it by the Annual General Meeting of Shareholders' held on March 26, 2014. Directed Share Issue is related to the acquisition of Suunnittelu ja Asennusten Valvonta – SAV Oy’s (“SAV Oy”) design and installation supervision business (“Business”) and SAV Oy’s subsidiaries. Business contract, which

Alfa Laval wins SEK 60 million brewery order in India

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order from a leading multinational brewery group, to supply a process solution for one of its plants in India. The order is booked in the Food Technology & Life Science segment, has a value of approximately SEK 60 million and delivery is scheduled for 2016.The order is for a complete process line, including separators, heat exchangers, mixers and fluid handling equipment. The process line will, among other things, handle yeast propagation, fermentation, maturation and filtration. Once

CHANGE OF THE NUMBER OF SHARES AND VOTES IN KARO BIO

STOCKHOLM, August 31, 2015 - Karo Bio AB (publ) today announced that the company’s total number of shares as per August 31, 2015 amounts to 46,992,903 shares, corresponding to an equal number of votes. The decrease in the number of shares and votes results from the recently completed reversed split of shares where 20 shares were consolidated into 1 new share. The reversed split was announced on July 7, 2015. FOR FURTHER INFORMATION, PLEASE CONTACT:Henrik Palm, CFO, telephone +46 70-540 40 14 or e-mail henrik.palm@karobio.se  ABOUT KARO BIOKaro Bio is a development company focused

Q-FREE- RUC CONTRACT IN NORWAY – 33 MNOK

Trondheim/Oslo 31 August, 2015: Q-Free has received an order from the Norwegian Public Roads Administration (NPRA) related to an extension of the ongoing contract for operation of the central system for toll collection in Norway. The order has a value of approximately NOK 33 million.- We are pleased to receive this 6 months extension order from the NPRA, for the continued operation of the Central System for AutoPASS in Norway, comments CEO in Q-Free, Thomas Falck. The extended contract period starts mid December 2015 and has a duration of six months. For further information, please

NeuroVive refocuses CicloMulsion development – discontinues acute myocardial infarction indication

CicloMulsion® development to continue in acute kidney injury and increased focus on development of other drug candidates. Shareholder information meeting to be held on 10th September 2015 in Lund, Sweden to present and discuss the NeuroVive portfolio. NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, announces it will not pursue development of CicloMulsion® in the indication of acute myocardial infarction (AMI). The company will now place strategic focus on progressing the research and development activities of CicloMulsion® in acute kidney injury, the development of its

Cortendo Announces Filing of Registration Statement for Proposed Initial Public Offering

August 31, 2015 – Göteborg, Sweden and Trevose, Pa., USA – Cortendo AB (publ) [ticker: CORT on NOTC-A], today announced it has filed a registration statement on Form F-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its ordinary shares. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Cortendo AB has applied to list its ordinary shares on The NASDAQ Global Market under the ticker symbol “SBBP.” BofA Merrill Lynch and Stifel are acting as joint book-running managers of the

Diamyd Medical licenses candidate drug for diabetes and gluten intolerance

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announces today that it has entered into an exclusive license agreement for using the gluten protein gliadin for the treatment and prevention of type 1 diabetes. Diamyd Medical aims at evaluating combination regimens of gliadin with compounds and antigens, such as for example GABA and GAD, for shutting off the inflammatory component in type 1 diabetes, gluten intolerance and other inflammatory diseases, for which preliminary patent applications have been filed. The world market for a successful new drug for treatment and prevention

Notice to Noreco Bondholders regarding interest payment due on NOR06 and NOR10

Stavanger, 31 August 2015: With reference to NOR10 - 6.50 per cent Norwegian Energy Company ASA Senior Secured Callable Bond Issue 2015/2018 - ISIN 001 069703.0, Norwegian Energy Company ASA announces that the interest payment due 6 September 2015 will be settled in cash. With reference to NOR06 - 6.5 per cent Noreco Norway AS Senior Secured Callable Bond Issue 2015/2018 ISIN 001 060632.0, the interest payment due 6 September 2015 will be settled through the issuance of additional bonds (i.e. PIK and not cash). Contact:investorrelations@noreco.com

Change in number of shares and votes in ÅF AB

For further information, please refer to:Emma Claesson, VP Human Resources & Communications     +46 72 209 47 39 The third opportunity to convert debentures into shares under the staff convertible debenture program decided by the annual general meeting 2012 occurred in August 2015. The number of shares before the conversion was 78 623 363 and the number of votes was 107 583 131. Through the conversion in August 2015 the numbers of B-shares and votes have increased by 151 305. The total number of shares after the conversion amounts to 78 774 668, of which 3 217 752 are A-shares and

There are no items matching the current filter
There are no more items matching the current filter
Back to top